Skip to main content
OpenTrials

Clinical trial condition

Adrenocortical Carcinoma

Explore clinical trials studying Adrenocortical Carcinoma. Study availability and eligibility vary by location and protocol.

40 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Adrenocortical Carcinoma trial results

Completed

A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

NCT00924989

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations
  • TGen Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of Colorado Denver Cancer Center Aurora, Colorado, United States
View all 35 locations
View Trial Details
Completed

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

NCT04373265

Conditions
ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +27 more
Locations
  • Site #150, Stanford Cancer Center Stanford, California, United States
  • Site #007, Moffitt Cancer Center Tampa, Florida, United States
  • Site #074, University of Michigan Medical School Ann Arbor, Michigan, United States
  • Site #030 Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions